About Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie
Clinical Trials at Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie
During the past decade, Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on
average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie"
#1 collaborator was "Proinnovera GmbH" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie
According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie" are
"Atopic Dermatitis" (3 trials), "Basal Cell Carcinoma" (2 trials), "Psoriasis" (2 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials) and "Cholinergic Urticaria" (1 trials). Many other conditions were trialed in "Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie
Most popular intervention types in "Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie" are "Drug" (10 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Atezolizumab" (2 trials), "Cobimetinib" (2 trials), "Dupilumab" (2 trials) and "Vemurafenib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie
The vast majority of trials in "Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie" are
11 trials for "All" genders.
Clinical Trials Status at Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie
Currently, there are NaN active trials in "Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie".
1 are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".